Journey Medical Corp reports results for the quarter ended in June - Earnings Summary

Journey Medical

09/08/2023 24:20

* Journey Medical Corp  DERM.OQ  reported a quarterly
adjusted
loss of 29 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 33 cents per share.
    * Revenue fell 6.1% to $17.17 million from a year ago;
analysts
expected $14.81 million. 
    * Journey Medical Corp's reported EPS for the quarter was a
loss
of 46 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Journey Medical Corp shares had risen by 34.6% this
quarter and
gained 11.5% so far this year.
    * The company reported a quarterly loss of $8.36 million.
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 11:20 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.33          -0.29          Beat
 Mar. 31 2023      -0.45          -0.57          Missed
 Dec. 31 2022      -0.47          -0.60          Missed
 Sep. 30 2022      -0.40          -0.57          Missed